Aspen Pharmacare Share Holder Equity 2017-2023 | APNHY
Aspen Pharmacare share holder equity from 2017 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
- Aspen Pharmacare share holder equity for the quarter ending June 30, 2023 was $4.864B, a 14.17% increase year-over-year.
- Aspen Pharmacare share holder equity for 2023 was $4.864B, a 4.19% increase from 2022.
- Aspen Pharmacare share holder equity for 2022 was $4.668B, a 9.09% increase from 2021.
- Aspen Pharmacare share holder equity for 2021 was $4.279B, a 4.01% decline from 2020.
Aspen Pharmacare Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$4,864 |
| 2022 |
$4,668 |
| 2021 |
$4,279 |
| 2020 |
$4,458 |
| 2019 |
$3,822 |
| 2018 |
$3,912 |
| 2017 |
$3,168 |
| 2016 |
$2,950 |
| 2015 |
$ |
Aspen Pharmacare Quarterly Share Holder Equity
(Millions of US $) |
| 2023-06-30 |
$4,864 |
| 2022-06-30 |
$4,668 |
| 2021-12-31 |
$4,677 |
| 2021-06-30 |
$4,279 |
| 2020-12-31 |
$4,260 |
| 2020-06-30 |
$4,458 |
| 2019-06-30 |
$3,822 |
| 2018-12-31 |
$3,655 |
| 2018-06-30 |
$3,912 |
| 2017-12-31 |
$3,256 |
| 2017-06-30 |
$3,168 |
| 2016-12-31 |
$2,843 |
| 2016-06-30 |
$2,950 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.038B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
